PHP
CBLL

Parkman Healthcare Partners’s CeriBell Inc CBLL Stock Holding History

Parkman Healthcare Partners’s Portfolio CBLL Stock Details CBLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-32,002
Closed -$828K – 107
2024
Q4 		$828K Buy
+32,002
New +$872K 0.11% 86

Other funds holding CBLL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parkman Healthcare Partners's CBLL Position: Q1 2025 in Review

Parkman Healthcare Partners sold out of CeriBell Inc (CBLL) in Q1 2025, closing a stake of 32,002 shares — an estimated $828K sold.

Parkman Healthcare Partners first reported a position in CBLL in Q4 2024 and held it in 1 quarter. The position peaked at $828K in Q4 2024. 86 funds tracked by Wall St. Rank hold CBLL as of Q1 2025.

  • Parkman Healthcare Partners reported no remaining CeriBell Inc position as of Q1 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 32,002 CeriBell Inc shares in Q1 2025, an estimated $828K.
  • Parkman Healthcare Partners first reported a position in CeriBell Inc in Q4 2024 and held it in 1 quarter.
  • Parkman Healthcare Partners's CeriBell Inc position peaked at $828K in Q4 2024.
  • 86 funds tracked by Wall St. Rank held CeriBell Inc as of Q1 2025.

Based on Parkman Healthcare Partners's 13F filing for Q1 2025, filed 15 May 2025.